RLAY · Forms 3, 4, 5

Insider trades at Relay Therapeutics, Inc.

2 insiders sold $1.2M of Relay Therapeutics, Inc. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for Relay Therapeutics, Inc. (RLAY) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Sanjiv PatelPresident and CEOSell48,199$18.10$872KForm 4
Thomas CatinazzoChief Financial OfficerSell17,511$18.58$325KForm 4
Thomas CatinazzoChief Financial OfficerSell206$19.26$4KForm 4
Donald A BergstromPresident, R&DSell8,530$18.97$162KForm 4
Thomas CatinazzoChief Financial OfficerSell17,717$18.94$336KForm 4
Sanjiv PatelPresident and CEOSell48,199$18.94$913KForm 4
Peter RahmerSee remarksSell4,508$20.03$90KForm 4
SVF Pauling (Cayman) Ltd10% ownerSell6,000,000$19.40$116.4MForm 4
Sanjiv PatelPresident and CEOSell48,199$20.33$980KForm 4
Thomas CatinazzoChief Financial OfficerSell17,717$19.74$350KForm 4
Thomas CatinazzoChief Financial OfficerSell1,459$18.61$27KForm 4
Peter RahmerSee remarksSell748$18.61$14KForm 4
Donald A BergstromPresident, R&DSell2,237$18.61$42KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.